On Tuesday, The Bill and Melinda Gates Foundation launched a $125 million research fund to support drugmakers and academics in the hunt for effective coronavirus treatments. The Gates Foundation and the Burroughs Wellcome Fund contributed $50 million each, and Mastercard (NYSE:MA) kicked in $25 million to launch the COVID-19 Therapeutics Accelerator. 

Right now, there are no vaccines available that can prevent people from becoming infected with SARS-CoV-2, the virus responsible for COVID-19. Nor have any antiviral treatments been clinically proven to stop the virus from replicating in infected patients. The Coalition for Epidemic Preparedness Innovations is a $650 million fund currently supporting the development of potential new vaccines, but most studies of experimental vaccines to see if they actually work take about a year.

Coronavirus blood vial.

Image source: Getty Images.

The COVID-19 Therapeutics Accelerator will devote its $125 million in funding to identifying potential treatments for patients who are already infected. These could have a more immediate impact because experimental antivirals can show evidence of efficacy in a matter of days.

The COVID-19 accelerator will help lower the financial risk taken on by companies and academics trying to develop antivirals specifically aimed at SARS-CoV-2. While there's a strong market for antivirals that tackle endemic viruses such as HIV, hepatitis, and influenza, developing treatments for diseases that may wind up eradicated from the planet isn't a sustainable business strategy.

At the moment, Gilead Sciences (NASDAQ:GILD) is testing remdesivir, which it developed as an Ebola treatment, to see it if it's effective against COVID-19, but that company boasts enormous cash flows that the vast majority of drug developers don't have.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.